FDA
- Status: approved
TT infant acellular Pertussis (TT infant acellular Pertussis) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
London School of Hygiene and Tropical Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.